- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 295/195 - Radicaux dérivés d'analogues azotés d'acides carboxyliques
Détention brevets de la classe C07D 295/195
Brevets de cette classe: 92
Historique des publications depuis 10 ans
8
|
9
|
10
|
7
|
9
|
2
|
5
|
4
|
7
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
The General Hospital Corporation | 4770 |
6 |
Reata Pharmaceuticals Holdings, LLC | 48 |
6 |
Massachusetts Institute of Technology | 10115 |
5 |
The Broad Institute, Inc. | 1842 |
5 |
Concentric Analgesics, Inc. | 23 |
4 |
President and Fellows of Harvard College | 6002 |
3 |
Rhizen Pharmaceuticals AG | 55 |
3 |
Bristol-myers Squibb Company | 4849 |
2 |
Ricoh Company, Ltd. | 13386 |
2 |
University of Florida Research Foundation, Inc. | 4053 |
2 |
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences | 74 |
2 |
Northeastern University | 1202 |
2 |
Novira Therapeutics, Inc. | 32 |
2 |
Oryzon Genomics S.A. | 109 |
2 |
Recordati Industria Chimica e Farmaceutica S.p.A. | 53 |
2 |
University of Virginia Patent Foundation | 1591 |
2 |
Virginia Tech Intellectual Properties, Inc. | 890 |
2 |
Corteva Agriscience LLC | 2692 |
2 |
Wisorig Technologies Pte. Limited | 9 |
2 |
The Regents of the University of California | 20108 |
1 |
Autres propriétaires | 35 |